Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin versus duloxetine for painful diabetic peripheral neuropathy
IRCT20250121064472N1Phase 2Completed
- Sponsor
- Islamic Azad University
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in diabetic polyneuropathy (DPN) comparing Pregabalin with Duloxetine (2 arms). Primary endpoints: VAS pain score before treatment, VAS pain score after treatment and 5 more. Started Mar 2025; status: completed.
02
Drugs
pregabalinduloxetine
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on IRCT20250121064472N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250121064472N1.